Oncotarget Small Cell Lung Cancer: Advancing Precision Medicine with Biomarker Research Precision medicine is an innovative approach to disease prevention and treatment that considers differences in... read more December 4, 2024
Oncotarget Cancer Dormancy and Tumor Recurrence: New Insights for Breast Cancer Cancer dormancy, followed by recurrence remains a poorly understood phenomenon in both cancer biology and... read more November 13, 2024
Oncotarget Next-Generation Antibodies for Cancer Therapy This study focuses on developing a new generation of antibodies that can get inside cancer... read more October 24, 2024
Oncotarget Targeting Stem Cell-like Traits: How miR-10b Inhibition Treats Metastatic Breast Cancer Our results demonstrate that inhibition of miR-10b using MN-anti-miR10b decreases the stemness of breast cancer... read more October 11, 2024
Oncotarget Key Roles of MIF, DDT, and CD74 in Melanoma Prognosis and Therapy In this new study, researchers present the first retrospective study evaluating differential gene expression of... read more August 28, 2024
Oncotarget Combining Regorafenib and TAS102 to Target Gastrointestinal Cancers and Overcome Cancer Stemness In this research paper, researchers demonstrate a promising new treatment option for refractory metastatic gastrointestinal... read more August 9, 2024
Oncotarget Novel Triple-Drug Combination to Fight Pancreatic Cancer In this new study, researchers unveiled a promising synergistic strategy for combating pancreatic cancer.—In... read more July 25, 2024
Oncotarget AI for Improved PET/CT Attenuation Correction in Prostate Cancer Imaging In this new study, researchers investigated an artificial intelligence (AI) tool that produces attenuation-corrected PET... read more July 11, 2024
Oncotarget Impact of Dual Immunotherapies Before Surgery in HR+/HER2-negative Breast Cancer In this new study, researchers assessed the feasibility of treating HR+/HER2-negative breast cancer patients... read more June 20, 2024
Oncotarget Dr. Blagosklonny’s Strategy: From Osimertinib to Preemptive Combinations This article dissects Dr. Mikhail V. Blagosklonny’s paradigm-shifting perspective on preemptive combinations for treating... read more June 6, 2024